Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Filings indexed 1,121 across all filing types
Latest filing 2009-12-14 Regulatory Filings
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Transfer of Product Distribution to Mayne 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is an announcement from HalcyGen Pharmaceuticals Limited regarding the transfer of marketing and distribution arrangements from Hospira Inc to Mayne Pharma International. It discusses operational changes and future financial impacts but does not contain financial statements, detailed financial results, or regulatory filings. The document is relatively short (4202 characters) and serves as a corporate announcement about a business arrangement rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is not a management or board change announcement, nor a voting result or legal proceeding. The content aligns best with a general Regulatory Filing (RNS) as it is a regulatory announcement about a business operational change that does not fit other specific categories.
2009-12-14 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under Corporations Law 671B titled 'Notice of change in interests of substantial holder.' It details changes in voting power and shareholdings of a substantial holder, Roger Aston, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2009-11-10 English
Change and Initial Substantial Holding 11 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in HalcyGen Pharmaceuticals Ltd. The content focuses on shareholding notifications and changes in substantial holdings rather than financial results, management changes, or other report types. This matches the definition of a Major Shareholding Notification (MRQ). The document length and detail confirm it is the notification itself, not just an announcement or certification.
2009-11-10 English
Change in substantial holding 6 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Notice of Change of Substantial Shareholding filed pursuant to section 671B of the Corporations Act 2001. It includes details about changes in voting power, relevant interests, and associations related to substantial shareholders. The presence of ASIC Form 604 and the focus on changes in shareholding percentages clearly indicate this is a Major Shareholding Notification. There is no indication that this is a full financial report, audit, or other types of filings. The document length and content are consistent with a substantial shareholder change notice rather than a report or announcement of a report.
2009-11-08 English
Change in Director`s Interest Notices x 5 14 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including number of shares held before and after changes, nature of changes, and consideration values. The document is a formal notification of directors' personal share transactions and interests. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document is lengthy and contains detailed transaction data, not just an announcement or summary, confirming it is the actual report type. Therefore, the correct classification is DIRS.
2009-11-04 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under Corporations Law section 671B, titled 'Notice of change in interests of substantial holder.' It details changes in voting power and shareholdings of a substantial shareholder, Bruce Mathieson, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2009-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.